Protective effects of N-acetylcysteine and β -glucan pretreatment on oxidative stress in cecal ligation and puncture model of sepsis

Journal of Investigative Surgery

Volumn 21, Issue 5, 2008, Pages 237-243

  Senoglu, N ^a   Yuzbasioglu, M F ^a   Aral, M ^a   Ezberci, M ^a   Kurutas, E Belge ^a   Bulbuloglu, E ^a   Ezberci, F ^a   Oksuz, H ^a   Ciragil, P ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

glucan; Immune response; N acetylcysteine; Septiceaemia

Indexed keywords

ACETYLCYSTEINE; ASIST; BETA GLUCAN; CATALASE; IMMUNEX; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIOXIDANT; AUTACOID; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; INFLAMMATION; LIGATION; LIVER LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SEPSIS; ANIMAL; BLOOD; COMPARATIVE STUDY; LIPID PEROXIDATION; METABOLISM; PUNCTURE; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; BETA-GLUCANS; CECUM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; LIGATION; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PUNCTURES; RATS; RATS, WISTAR; SEPSIS;

EID: 61749088153     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930802180136     Document Type: Article

References (31)

1. Adrie C, Pinsky MR. The inflammatory balance in human sepsis. Intensive Care Med. 2000;26:364-375.
2. Marsh CB, Wewers MD. The pathogenesis of sepsis: factors that modulate the response to gram-negative bacterial infection. Clin Chest Med. 1996;17:183-197.
3. Gutteridge JMC, Mitchell J. Redox imbalance in the critically ill. Br Med Bull. 1999;55:49-75.
4. Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth. 2003;90:221-232.
5. Lovat R, Preiser JC. Antioxidant therapy in intensive care. Curr Opin Crit Care. 2003;9:266-270.
6. Spapen H, Zhang H, Demanet C, et al. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest. 1998;113:1616-1624.
7. Verhasselt V, Vanden Berghe W, Vanderheyde N, et al. N-Acetyl-L- cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kB inhibition. J. Immunol. 1999;162:2569-2574.
8. Cisneros RL, Gibson FC, Tzianabos AO. Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis. Infect Immun. 1996;64:2201-2205.
9. Onderdonk AB, Cisneros RL, Hinkson P, et al. Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo. Infect Immun. 1992;60:1642-1647.
10. Sener G, Toklu H, Ercan F, et al. Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol. 2005,5:1387-1396.
11. Babayigit H, Kucuk C. Sozuer E, Yazici C, et al. Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats. Intensive Care Med. 2005;31:865-870.
12. Williams DL, Ha T, Li C, et al. Inhibiting early activation of tissue nuclear factor-EB and nuclear factor interleukin 6 with (1-3)-h-d-glucan increases long-term survival in polymicrobial sepsis. Surgery. 1999;126:54-65.
13. Dhainaut JF, Marin N, Mignon A, et al. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med. 2001;29(7 Suppl.):S42-S47.
14. Baker CC, Chaudry IH, Gaines HO, et al. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94:331-335.
15. Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol. 1983;23:239-257.
16. Beutler E. Red Cell Metabolism 2nd edition. New York: Grune and Stratton; 1975:261-265.
17. Ohkawa H, Ohishi N, Tagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
18. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
19. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
20. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ. 2003;326:262-266.
21. Walley KR, Lukacs NW, Standiford TJ, et al. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun. 1996;64:4733-4738.
22. Cao Q, Mak KM, Lieber CS. Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB. Biochem Biophys Res Commun. 2002;294:849-8453.
23. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215:356-362.
24. Neidhardt R, Keel M,Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863-870.
25. Pinsky MR. Antioxidant therapy for severe sepsis: promise and perspective. Crit Care Med. 2003;31:2697-2698.
26. Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003;31:2574-2578.
27. Brown GD, Herre J, Williams DL, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med. 2003;197:1119-1124.
28. Scandalios JG. Oxygen stress and superoxide dismutases. Plant Physiol. 1993;101:7-12.
29. Liaudet L, Mapley JG, Soriano FG, et al. Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med. 2001;164:1213-1220.
30. Hartley DP, Kolaja KL, Reichard J, et al. 4-Hydroxynonenal and mal-ondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization. Toxicol Appl Pharmacol. 1999;161:23-33.
31. Sampey BP, Korourian S, Ronis MJ, et al. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin Exp Res. 2003;27:1015-1022.